Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 12, 2026Reported sale · Form 4KEVIN F MCLAUGHLIN · $311.7KOpen the filing ↗
- Aug 12, 2026Notice of sale · Form 144MCLAUGHLIN KEVIN F · Director · $308.8KOpen the filing ↗
- Aug 3, 2026Reported sale · Form 4Michael Halpin, Chief Operating Officer · $468.4KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record1,43412 flagged findings
Reported transactions (Form 4)80since Feb 24, 2026 · and 2 other holdings
Corporate events (8-K)30since Sep 19, 2017
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
What the company does
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-07capital return (buybacks/dividends)recentOpen filing ↗“…17 Table of Contents The Revolving Credit Agreement contains usual and customary restrictions on the ability of the Company…”
- 2026-02-26capital return (buybacks/dividends)recentOpen filing ↗“…terms of our Revolving Credit Agreement, contain, and any of our other future debt agreements may contain, covenant restrictions…”
+1 more passage from the same document
- “…Revolving Credit Agreement). The Revolving Credit Agreement contains usual and customary restrictions on the ability of the Company…”
- 2026-02-26Department of Justice inquiryrecentOpen filing ↗“…distribution, sale and promotion of biological products and devices are subject to regulation by various federal, state,…”
+1 more passage from the same document
- “…of substantial harm to the public health. The FDA may also impose operating restrictions on a company-wide basis, enjoin and…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 1,434)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 14, 26Form 4 ↗Insider transaction
- Aug 13, 26SCHEDULE 13G/A ↗Passive stake · Soleus Capital Master Fund, L.P. · 2.8% · event on Jun 30, 26 · amendment
- Aug 12, 26Form 144 ↗Notice of proposed sale
- Aug 5, 26Form 4 ↗Insider transaction
- Aug 3, 26Form 144 ↗Notice of proposed sale
- Jul 31, 26Form 4 ↗Insider transaction
- Jul 30, 26Form 144 ↗Notice of proposed sale
- Jul 30, 2610-Q ↗Quarterly report
- Jul 30, 268-K ↗Current report · Results
Notice of proposed sale · 4 Form 144 filingsshow all 4hide
- Jun 26, 26Form 144 ↗Notice of proposed sale
- Jun 26, 26Form 144 ↗Notice of proposed sale
- Jun 26, 26Form 144 ↗Notice of proposed sale
- Jun 26, 26Form 144 ↗Notice of proposed sale
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Jun 18, 26Form 144 ↗Notice of proposed sale
- Jun 18, 26Form 144 ↗Notice of proposed sale
- Jun 4, 26Form 4 ↗Insider transaction
- Jun 2, 26Form 144 ↗Notice of proposed sale
- May 18, 268-K ↗Current report · Bylaws or fiscal year change
- May 15, 26Form 4 ↗Insider transaction
1,434 filings on record, the oldest from Mar 7, 97.
Listing the 25 most recent filings of the 1,434 on record.
810559
- May 2, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- May 5, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Aug 2, 22Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Apr 29, 22A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Feb 24, 22A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Feb 2, 22Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Aug 27, 21Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Jun 21, 21A senior executive left or was appointed8-K 5.02 ↗
- Jun 2, 21A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Feb 12, 21Entered a material agreement+4 more in the same filing8-K 1.01 ↗
4 senior executive changes2019 – 2021show all 4hide
- Jan 25, 21A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Sep 8, 20A senior executive left or was appointed8-K 5.02 ↗
- May 1, 20A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jun 3, 19A senior executive left or was appointed8-K 5.02 ↗
- May 7, 19Entered a material agreement8-K 1.01 ↗
8 older filings not shown · The record reaches back to Jan 13, 05.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Jun 16, 14Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
- May 24, 13Listing notice (8-K 3.01)8-K 3.01 ↗
- May 13, 13Listing notice (8-K 3.01)8-K 3.01 ↗
- Mar 29, 13Restructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
- Feb 14, 11Past accounts declared unreliable and being restated+2 more in the same filing8-K 4.02 ↗
- Oct 7, 09Listing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
- Jun 18, 08Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Dec 21, 07Listing notice (8-K 3.01)8-K 3.01 ↗
The full record holds 8 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- BlackRock, Inc.15.1%Mar 31, 25SCHEDULE 13G/A ↗
- STATE STREET CORPORATION5.6%Sep 30, 25SCHEDULE 13G ↗
- Vanguard Capital Management5.1%Mar 31, 26SCHEDULE 13G ↗
- Brown Capital Management, LLC3.9%Sep 30, 25SCHEDULE 13G/A ↗2 earlier filings
- Soleus Capital Master Fund, L.P.2.8%Jun 30, 26SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Aug 12, MCLAUGHLIN KEVIN F filed notice of intent to sell up to $309K. That is about 0.01% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $312K on Aug 12, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+6 more recent notices · 6 with a later sale
- Aug 12, 26Sell$312KKEVIN F MCLAUGHLIN↗
- Aug 3, 26Sell$468KMichael HalpinChief Operating Officer↗
- Jul 30, 26Sell$73KJONATHAN SIEGALPrincipal Accounting Officer↗
- Jul 30, 26Sell$122KJONATHAN SIEGALPrincipal Accounting Officer↗
- Jul 30, 26Sell$24KJONATHAN SIEGALPrincipal Accounting Officer↗
- Jun 26, 26Sell$685KSean C. FlynnChief Legal Officer↗
- Jun 26, 26Sell$225KJonathan Mark HopperChief Medical Officer↗
- Jun 26, 26Sell$224KJoseph Anthony Mara JrChief Financial Officer↗
- Jun 26, 26Sell$10KJONATHAN SIEGALPrincipal Accounting Officer↗
- Jun 26, 26Sell$112KJONATHAN SIEGALPrincipal Accounting Officer↗
- Jun 18, 26Sell$603KSean C. FlynnChief Legal Officer↗
- Jun 18, 26Sell$402KMichael HalpinChief Operating Officer↗
There are 8 more transactions in this stretch.
Stock compensation, tax and giftsshow the 20 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Aug 12, 26Compensation$91KKEVIN F MCLAUGHLIN↗
- Aug 3, 26Compensation$167KMichael HalpinChief Operating Officer↗
- Jul 30, 26Compensation$52KJONATHAN SIEGALPrincipal Accounting Officer↗
- Jul 30, 26Compensation$75KJONATHAN SIEGALPrincipal Accounting Officer↗
- Jul 30, 26Compensation$15KJONATHAN SIEGALPrincipal Accounting Officer↗
- Jun 26, 26Compensation$244KSean C. FlynnChief Legal Officer↗
- Jun 26, 26Compensation$149KJonathan Mark HopperChief Medical Officer↗
- Jun 26, 26Compensation$75KJONATHAN SIEGALPrincipal Accounting Officer↗
- Jun 18, 26Compensation$244KSean C. FlynnChief Legal Officer↗
- Jun 18, 26Compensation$167KMichael HalpinChief Operating Officer↗
- Jun 2, 26Compensation$73KJonathan Mark HopperChief Medical Officer↗
- May 13, 26Compensation$9KKEVIN F MCLAUGHLIN↗
- May 13, 26Compensation$46KKEVIN F MCLAUGHLIN↗
- Apr 29, 26Compensationamount n/aLISA WRIGHT↗
- Apr 29, 26Compensationamount n/aAlan L Rubino↗
- Apr 29, 26Compensationamount n/aROBERT L ZERBE MD↗
- Apr 29, 26Compensationamount n/aPaul K Wotton↗
- Apr 29, 26Compensationamount n/aHeidi Hagen↗
- Apr 29, 26Compensationamount n/aKEVIN F MCLAUGHLIN↗
- Apr 2, 26Compensation$38KJonathan Mark HopperChief Medical Officer↗
The full record holds 456 transactions and goes back to Mar 31, 22.
Its sector and its market
Vericel Corporation among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Vericel Corporation, the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Vericel Corporation in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 1,434 documents on file, from Mar 7, 1997 to Aug 14, 2026.
- Company description
- Wikipedia, read on Sep 3, 2026.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.